These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29564390)

  • 41. [
    Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F
    Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Head-to-Head Comparison of
    Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L
    J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of bone-seeking novel radiotracer
    Passah A; Tripathi M; Ballal S; Yadav MP; Kumar R; Roesch F; Meckel M; Sarathi Chakraborty P; Bal C
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):41-49. PubMed ID: 27455986
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Sinnes JP; Bauder-Wüst U; Schäfer M; Moon ES; Kopka K; Rösch F
    EJNMMI Radiopharm Chem; 2020 Nov; 5(1):28. PubMed ID: 33242189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Translation and First In-Human Use of [
    Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
    Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA
    Moon ES; Elvas F; Vliegen G; De Lombaerde S; Vangestel C; De Bruycker S; Bracke A; Eppard E; Greifenstein L; Klasen B; Kramer V; Staelens S; De Meester I; Van der Veken P; Rösch F
    EJNMMI Radiopharm Chem; 2020 Jul; 5(1):19. PubMed ID: 32728930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a
    Edem PE; Jørgensen JT; Nørregaard K; Rossin R; Yazdani A; Valliant JF; Robillard M; Herth MM; Kjaer A
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy.
    Luyten K; Van Loy T; Cawthorne C; Deroose CM; Schols D; Bormans G; Cleeren F
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriers.
    Ogawa K; Ishizaki A; Takai K; Kitamura Y; Kiwada T; Shiba K; Odani A
    PLoS One; 2013; 8(12):e84335. PubMed ID: 24391942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog
    Sauter AW; Mansi R; Hassiepen U; Muller L; Panigada T; Wiehr S; Wild AM; Geistlich S; Béhé M; Rottenburger C; Wild D; Fani M
    J Nucl Med; 2019 Mar; 60(3):393-399. PubMed ID: 30002107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide.
    Putzer D; Kroiss A; Waitz D; Gabriel M; Traub-Weidinger T; Uprimny C; von Guggenberg E; Decristoforo C; Warwitz B; Widmann G; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):364-72. PubMed ID: 23151915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical evaluation of [
    Gaertner FC; Plum T; Kreppel B; Eppard E; Meisenheimer M; Strunk H; Bundschuh RA; Sinnes JP; Rösch F; Essler M
    Nucl Med Biol; 2019; 76-77():1-9. PubMed ID: 31520872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [
    Jaswal AP; Meena VK; Prakash S; Pandey A; Singh B; Mishra AK; Hazari PP
    Front Med (Lausanne); 2017; 4():72. PubMed ID: 28649566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and biological evaluation of 68Ga-bis-DOTA-PA as a potential agent for positron emission tomography imaging of necrosis.
    Prinsen K; Cona MM; Cleynhens BJ; Li J; Vanbilloen H; Dyubankova N; Lescrinier E; Ni Y; Bormans GM; Verbruggen AM
    Nucl Med Biol; 2013 Aug; 40(6):816-22. PubMed ID: 23915800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy.
    Souche C; Fouillet J; Rubira L; Donzé C; Deshayes E; Fersing C
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Syntheses and evaluation of
    Chakraborty S; Goswami D; Chakravarty R; Mohammed SK; Sarma HD; Dash A
    Chem Biol Drug Des; 2018 Sep; 92(3):1618-1626. PubMed ID: 29729071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
    Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T
    Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.